Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating diabetes

A composition and diabetes technology, applied in drug combination, metabolic disease, pharmaceutical formula, etc., can solve the problems of diabetic patients with unsatisfactory effects of improving the overall function of the body and preventing and treating complications, etc., so as to relieve migratory tingling pain , improve the acceleration of microcirculation, and improve the effect of fatigue-free body

Pending Publication Date: 2017-07-25
李忠
View PDF3 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although the above-mentioned composition can significantly improve the adverse reactions of gliclazide and control blood sugar better than simple gliclazide, it is still not effective in improving the overall function of the body of diabetic patients and preventing complications. satisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Example 1: A pharmaceutical composition for treating diabetes is prepared from the following raw materials by weight ratio: 8 parts of gliclazide, 3 parts of vitB6, 0.05 parts of viB12, 300 parts of American ginseng, and 400 parts of Panax notoginseng. The production method is to select clean American ginseng and Panax notoginseng raw materials to be pulverized to 100-200 mesh first, then mix evenly with gliclazide powder, vitB6 powder, and viB12 powder, and press into tablets according to the conventional method of pharmacy, each tablet is 2 grams, If conventional auxiliary materials such as starch or cyclodextrin are added, the amount should be controlled within 20% by weight of the composition.

Embodiment 2

[0027] Example 2: A pharmaceutical composition for treating diabetes is prepared from the following raw materials by weight ratio: 16 parts of gliclazide, 3 parts of vitB6, 0.025 parts of viB12, 500 parts of American ginseng, and 300 parts of Panax notoginseng. The production method is to select clean American ginseng and Panax notoginseng raw materials to be pulverized to 100-200 mesh first, then mix evenly with gliclazide powder, vitB6 powder, and viB12 powder, and press into tablets according to the conventional method of pharmacy, each tablet is 2 grams, If conventional auxiliary materials such as starch or cyclodextrin are added, the amount should be controlled within 20% by weight of the composition.

Embodiment 3

[0028] Example 3: A pharmaceutical composition for treating diabetes is prepared by weight ratio of the following raw materials: 16 parts of gliclazide, 3 parts of vitB6, 0.025 parts of viB12, 500 parts of American ginseng, and 300 parts of Panax notoginseng. The production method is to select clean American ginseng and notoginseng raw materials and crush them to 100-200 mesh first, then mix them evenly with gliclazide powder, vitB6 powder, and viB12 powder, and press them into pills according to the conventional method of pharmacy. If adding conventional auxiliary materials such as The amount of starch, cyclodextrin and honey should be controlled within 2 times the weight of the composition, and the weight of each pill should be controlled within 6 grams.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating diabetes. The pharmaceutical composition is prepared from 8 to 16 parts by weight of gliclazide, 1 to 3 parts by weight of vitB6, 0. 025 to 0.1 parts by weight of viB12, 300 to 500 parts by weight of American ginseng and 300 to 500 parts by weight of pseudo-ginseng. The American ginseng in the pharmaceutical composition can balance blood sugar (bilaterally adjust blood sugar), has effects of nourishing yin and tonifying yang, reinforcing the vital essence and relieving collapse, resisting oxidation and removing free radicals, and can obviously improve human immunity through long-term use. Pseudo-ginseng in the pharmaceutical composition can improve microcirculation, can accelerate complication recovery, can reduce blood fat and blood sugar, has effects of promoting blood circulation to remove blood stasis, relaxing tendons and activating collaterals, resisting oxidation and aging and removing free radicals, and can produce good hypoglycemic synergism with gliclazide and good free radical removal synergism with American ginseng. The vitB6 and viB12 have a function of regulating nerves.

Description

technical field [0001] The invention relates to a medicine for treating diabetes, in particular to a medicine composition for treating diabetes and a production method thereof. Background technique [0002] Diabetes mellitus is a metabolic disease characterized by hyperglycemia caused by insulin secretion defects or insulin action disorders. Sustained hyperglycemia and long-term metabolic disorders can lead to systemic tissues and organs, especially the eyes, kidneys, and cardiovascular system. and nervous system damage and dysfunction and failure. According to relevant reports, there are as many as 12 million diabetic patients with high blood pressure, 5 million stroke patients, more than 6 million coronary heart disease patients, 450,000 blind patients, and 500,000 uremia patients. It is the second killer in modern diseases, and its harm to the human body is second only to cancer. Gliclazide is a sulfonylurea drug, which mainly acts on the sulfonylurea receptors on the s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/258A61P3/10A61K31/64A61K31/4415A61K31/714
Inventor 李忠
Owner 李忠
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com